Gene and Cell Therapies:Market Access and Funding(Pharmaceuticals, Health Economics and Market Access)

基因与细胞疗法:市场准入与资金(精装)

药理学

售   价:
2628.00
发货周期:预计5-7周发货
作      者
出  版 社
出版时间
2020年05月22日
装      帧
精装
ISBN
9780367483845
复制
页      码
144
开      本
6-1/8 x 9-1/4
语      种
英文
综合评分
暂无评分
我 要 买
- +
库存 50 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
The major advances in the field of biotechnology and molecular biology in the 21st century have led to a better understanding of the pathophysiology of several diseases. A new generation of biopharmaceuticals has emerged, including a wide and heterogeneous range of innovative cell and gene therapies. These therapies aim to prevent or treat chronic or serious life-threatening diseases, previously considered incurable. This book describes the evolution and adaptation of the regulatory environment to assess these therapies in contrast with the resistance of health technology assessment (HTA) agencies and payers to acknowledge the specificity of cell and gene therapies and the need of adaptation of existing decision-making frameworks. This book provides insights on the learnings from current cell and gene therapies’ experience (regulatory approval, HTA, and market access), in addition to future trends to enhance patient access to these therapies. Key Features: Describes the potential change of treatment paradigm and the specificity of cell and gene therapies including the gradual move from repeated treatment administration to one single administration with potential for a definite cure Highlights the challenges at the HTA level Discusses the affordability of future cell and gene therapies and the possible challenges for health insurance systems Provides potential solutions to address these challenges and ensure patient access to innovation while maintaining the sustainability of healthcare systems
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个